MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 905/S. 733, to amend Part B of title XVIII of the Social Security Act HR 3765, Temporary Payroll Tax Cut Continuation Act of 2011 Meetings/education regarding physician and pharmacy reimbursement issues Deficit reduction issues related to Medicare and Medicaid
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
| MATT BROW | — |
| KEAGAN R LENIHAN New | — |
| GEOFF WERTH | — |
Taxation/Internal Revenue Code TAX
Meetings/education regarding the implementation of new medical device tax. Meetings/education regarding proposals to repeal LIFO.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Pharmacy PHA
Meetings/education regarding pharmacy issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Health Issues HCR
Meetings/education regarding incentives for health information technology, health care reform implementation and other healthcare policy issues. Education regarding existing Vaccines for Children program. Proposed regulation of medical software.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Veterans VET
Education regarding the existing Department of Veterans' Affairs Pharmaceutical Prime Vendor contract.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.